840 related articles for article (PubMed ID: 23524253)
1. Thermoreversible in situ gelling poloxamer-based systems with chitosan nanocomplexes for prolonged subcutaneous delivery of heparin: design and in vitro evaluation.
Radivojša M; Grabnar I; Ahlin Grabnar P
Eur J Pharm Sci; 2013 Sep; 50(1):93-101. PubMed ID: 23524253
[TBL] [Abstract][Full Text] [Related]
2. Prolonged subcutaneous delivery of low molecular weight heparin based on thermoresponsive hydrogels with chitosan nanocomplexes: Design, in vitro evaluation, and cytotoxicity studies.
Radivojša Matanović M; Grabnar I; Gosenca M; Grabnar PA
Int J Pharm; 2015 Jul; 488(1-2):127-35. PubMed ID: 25912230
[TBL] [Abstract][Full Text] [Related]
3. Development and preclinical pharmacokinetics of a novel subcutaneous thermoresponsive system for prolonged delivery of heparin.
Matanović MR; Grabnar PA; Voinovich D; Golob S; Mijovski MB; Grabnar I
Int J Pharm; 2015 Dec; 496(2):583-92. PubMed ID: 26529577
[TBL] [Abstract][Full Text] [Related]
4. A novel poloxamers/hyaluronic acid in situ forming hydrogel for drug delivery: rheological, mucoadhesive and in vitro release properties.
Mayol L; Quaglia F; Borzacchiello A; Ambrosio L; La Rotonda MI
Eur J Pharm Biopharm; 2008 Sep; 70(1):199-206. PubMed ID: 18644705
[TBL] [Abstract][Full Text] [Related]
5. Preparation, optimization, and in-vitro/in-vivo/ex-vivo characterization of chitosan-heparin nanoparticles: drug-induced gelation.
Shahbazi MA; Hamidi M; Mohammadi-Samani S
J Pharm Pharmacol; 2013 Aug; 65(8):1118-33. PubMed ID: 23837580
[TBL] [Abstract][Full Text] [Related]
6. Influence of additives on a thermosensitive hydrogel for buccal delivery of salbutamol: relation between micellization, gelation, mechanic and release properties.
Zeng N; Dumortier G; Maury M; Mignet N; Boudy V
Int J Pharm; 2014 Jun; 467(1-2):70-83. PubMed ID: 24699353
[TBL] [Abstract][Full Text] [Related]
7. Poloxamer/cyclodextrin/chitosan-based thermoreversible gel for intranasal delivery of fexofenadine hydrochloride.
Cho HJ; Balakrishnan P; Park EK; Song KW; Hong SS; Jang TY; Kim KS; Chung SJ; Shim CK; Kim DD
J Pharm Sci; 2011 Feb; 100(2):681-91. PubMed ID: 20803575
[TBL] [Abstract][Full Text] [Related]
8. Chitosan in situ gelation for improved drug loading and retention in poloxamer 407 gels.
Ur-Rehman T; Tavelin S; Gröbner G
Int J Pharm; 2011 May; 409(1-2):19-29. PubMed ID: 21335076
[TBL] [Abstract][Full Text] [Related]
9. High encapsulation efficiency of poloxamer-based injectable thermoresponsive hydrogels of etoposide.
Soni G; Yadav KS
Pharm Dev Technol; 2014 Sep; 19(6):651-61. PubMed ID: 23879721
[TBL] [Abstract][Full Text] [Related]
10. Poloxamer-based in situ hydrogels for controlled delivery of hydrophilic macromolecules after intramuscular injection in rats.
Zhang K; Shi X; Lin X; Yao C; Shen L; Feng Y
Drug Deliv; 2015 May; 22(3):375-82. PubMed ID: 24601854
[TBL] [Abstract][Full Text] [Related]
11. Development and characterisation of modified poloxamer 407 thermoresponsive depot systems containing cubosomes.
Kojarunchitt T; Hook S; Rizwan S; Rades T; Baldursdottir S
Int J Pharm; 2011 Apr; 408(1-2):20-6. PubMed ID: 21272624
[TBL] [Abstract][Full Text] [Related]
12. Characterization of thermosensitive chitosan-based hydrogels by rheology and electron paramagnetic resonance spectroscopy.
Kempe S; Metz H; Bastrop M; Hvilsom A; Contri RV; Mäder K
Eur J Pharm Biopharm; 2008 Jan; 68(1):26-33. PubMed ID: 17870449
[TBL] [Abstract][Full Text] [Related]
13. Formulation, functional evaluation and ex vivo performance of thermoresponsive soluble gels - A platform for therapeutic delivery to mucosal sinus tissue.
Pandey P; Cabot PJ; Wallwork B; Panizza BJ; Parekh HS
Eur J Pharm Sci; 2017 Jan; 96():499-507. PubMed ID: 27771516
[TBL] [Abstract][Full Text] [Related]
14. Modified thermoresponsive Poloxamer 407 and chitosan sol-gels as potential sustained-release vaccine delivery systems.
Kojarunchitt T; Baldursdottir S; Dong YD; Boyd BJ; Rades T; Hook S
Eur J Pharm Biopharm; 2015 Jan; 89():74-81. PubMed ID: 25481034
[TBL] [Abstract][Full Text] [Related]
15. Thermosensitive micelles-hydrogel hybrid system based on poloxamer 407 for localized delivery of paclitaxel.
Ju C; Sun J; Zi P; Jin X; Zhang C
J Pharm Sci; 2013 Aug; 102(8):2707-17. PubMed ID: 23839931
[TBL] [Abstract][Full Text] [Related]
16. Design and Development of Thermoreversible Ophthalmic In Situ Hydrogel of Moxifloxacin HCl.
Shastri DH; Prajapati ST; Patel LD
Curr Drug Deliv; 2010 Jul; 7(3):238-43. PubMed ID: 20497100
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo evaluation of an in situ gel forming system for the delivery of PEGylated octreotide.
Erfani Jabarian L; Rouini MR; Atyabi F; Foroumadi A; Nassiri SM; Dinarvand R
Eur J Pharm Sci; 2013 Jan; 48(1-2):87-96. PubMed ID: 23131800
[TBL] [Abstract][Full Text] [Related]
18. Smart gelation of chitosan solution in the presence of NaHCO3 for injectable drug delivery system.
Liu L; Tang X; Wang Y; Guo S
Int J Pharm; 2011 Jul; 414(1-2):6-15. PubMed ID: 21554937
[TBL] [Abstract][Full Text] [Related]
19. Enhancing and sustaining the topical ocular delivery of fluconazole using chitosan solution and poloxamer/chitosan in situ forming gel.
Gratieri T; Gelfuso GM; de Freitas O; Rocha EM; Lopez RF
Eur J Pharm Biopharm; 2011 Oct; 79(2):320-7. PubMed ID: 21641994
[TBL] [Abstract][Full Text] [Related]
20. Baicalein and hydroxypropyl-γ-cyclodextrin complex in poloxamer thermal sensitive hydrogel for vaginal administration.
Zhou Q; Zhong L; Wei X; Dou W; Chou G; Wang Z
Int J Pharm; 2013 Sep; 454(1):125-34. PubMed ID: 23850236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
